HHS to Expand Negotiating Power for Medicare

(From The Washington Examiner)

The Trump administration is giving private plans more power to negotiate to lower drug prices for seniors for physician-administered drugs.

The Centers for Medicare & Medicaid Services said that the new policy is part of a greater effort by the Trump administration to lower drug prices. The agency’s new policy applies to Medicare Advantage, a program that lets seniors use their Medicare benefits to buy a private plan.

Click here for article.